New Zealand markets open in 7 hours 57 minutes

Voyageur Pharmaceuticals Ltd. (VM.V)

TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
0.0550+0.0050 (+10.00%)
As of 09:53AM EDT. Market open.
Currency in CAD

Valuation measures4

Market cap (intra-day) 6.94M
Enterprise value 6.98M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)4.83
Enterprise value/revenue N/A
Enterprise value/EBITDA -5.01

Trading information

Stock price history

Beta (5Y monthly) 0.49
52-week change 3-37.50%
S&P500 52-week change 323.57%
52-week high 30.0900
52-week low 30.0350
50-day moving average 30.0658
200-day moving average 30.0593

Share statistics

Avg vol (3-month) 338.38k
Avg vol (10-day) 325.03k
Shares outstanding 5138.81M
Implied shares outstanding 6138.81M
Float 8124.63M
% held by insiders 110.21%
% held by institutions 10.00%
Shares short (15 Apr 2024) 49.54k
Short ratio (15 Apr 2024) 41.26
Short % of float (15 Apr 2024) 4N/A
Short % of shares outstanding (15 Apr 2024) 40.02%
Shares short (prior month 15 Mar 2024) 42k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 307 Mar 2017
Ex-dividend date 4N/A
Last split factor 21:2
Last split date 307 Mar 2017

Financial highlights

Fiscal year

Fiscal year ends 30 Nov 2023
Most-recent quarter (mrq)29 Feb 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-27.95%
Return on equity (ttm)-71.00%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -1.19M
Net income avi to common (ttm)-1.35M
Diluted EPS (ttm)-0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)253.25k
Total cash per share (mrq)0
Total debt (mrq)40k
Total debt/equity (mrq)2.54%
Current ratio (mrq)0.48
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-700.12k
Levered free cash flow (ttm)-204.67k